These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32063235)

  • 1. Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
    Andrews SC; Langbehn DR; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC;
    Psychol Med; 2021 Jun; 51(8):1338-1344. PubMed ID: 32063235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease.
    Andrews SC; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC
    Neuropsychology; 2018 Nov; 32(8):958-965. PubMed ID: 30211612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    Cogn Behav Neurol; 2021 Dec; 34(4):295-302. PubMed ID: 34851867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study.
    van der Zwaan KF; Jacobs M; van Zwet EW; Roos RAC; de Bot ST
    J Huntingtons Dis; 2021; 10(2):269-276. PubMed ID: 33523014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.
    Vinther-Jensen T; Larsen IU; Hjermind LE; Budtz-Jørgensen E; Nielsen TT; Nørremølle A; Nielsen JE; Vogel A
    Orphanet J Rare Dis; 2014 Jul; 9():114. PubMed ID: 25026978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study.
    Baake V; Coppen EM; van Duijn E; Dumas EM; van den Bogaard SJA; Scahill RI; Johnson H; Leavitt B; Durr A; Tabrizi SJ; Craufurd D; Roos RAC;
    Neuroimage Clin; 2018; 19():66-70. PubMed ID: 30035003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apathy and Impulsivity Co-Occur in Huntington's Disease.
    Morris LA; Horne KL; Paermentier L; Buchanan CM; MacAskill M; Myall D; Husain M; Roxburgh R; Anderson T; Heron CL
    Brain Behav; 2024 Oct; 14(10):e70061. PubMed ID: 39344371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
    Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Performance and Apathy Predict Unemployment in Huntington's Disease Mutation Carriers.
    Jacobs M; Hart EP; Roos RAC
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):188-193. PubMed ID: 29325477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.
    Osborne-Crowley K; Andrews SC; Labuschagne I; Nair A; Scahill R; Craufurd D; Tabrizi SJ; Stout JC;
    J Int Neuropsychol Soc; 2019 May; 25(5):453-461. PubMed ID: 30767839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive decline in Huntington's disease expansion gene carriers.
    Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
    Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD dataset.
    Harris KL; Mason SL; Barker RA
    J Neurol; 2022 Jul; 269(7):3501-3510. PubMed ID: 35165768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The temporal dynamics of mood and their association with depressive symptoms in Huntington's disease.
    Bilal H; Harding IH; Stout JC
    J Affect Disord; 2023 May; 328():22-28. PubMed ID: 36791969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.